# A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis

> **NCT02598440** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 341 (actual)

## Conditions studied

- Postmenopausal Osteoporosis

## Interventions

- **DRUG:** Alendronate
- **DRUG:** Ibandronate

## Key facts

- **NCT ID:** NCT02598440
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 341 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02598440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02598440, "A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02598440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*